Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
6
|
| gptkbp:bfsParent |
gptkb:Trazodone
|
| gptkbp:category |
gptkb:C
|
| gptkbp:dosage_form |
Extended-release tablet
|
| gptkbp:effective_date |
2010-01-01
|
| gptkbp:form |
gptkb:tablet
|
| gptkbp:has_ability |
150 mg
300 mg |
| https://www.w3.org/2000/01/rdf-schema#label |
Oleptro
|
| gptkbp:ingredients |
gptkb:Trazodone
|
| gptkbp:interacts_with |
Alcohol
Anticoagulants Antidepressants CNS depressants MAO inhibitors |
| gptkbp:is_used_for |
gptkb:Depression
|
| gptkbp:manager |
Oral
|
| gptkbp:manufacturer |
gptkb:Rugby_Laboratories
|
| gptkbp:side_effect |
gptkb:Nausea
Dizziness Headache Drowsiness Dry mouth |